The notices it replaced
1 notice since 2015, oldest first, each with its awards since FY2014.
- Posted 2015RFA-HL-16-02519 awards
- Posted 2019RFA-HL-20-012This notice, closed · 16 awards
Replaced by RFA-HL-23-005.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 35
- 35 new
- Median first-year cost
- $805,229
- $27,276,991 in all
- Institutions
- 26
- 35 contact PIs
- Patents
- 6
- from 3 funded projects
Awards by fiscal year
0
0
0
8
4
7
6
5
5
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- UNIVERSITY OF MICHIGAN AT ANN ARBOR4
- UNIVERSITY OF ALABAMA AT BIRMINGHAM3
- EMORY UNIVERSITY2
- MASSACHUSETTS GENERAL HOSPITAL2
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH2
and 21 other institutions
Most frequent study sections
- Special Emphasis Panel (ZHL1 CSR-I (O2))19
- Special Emphasis Panel (ZHL1 CSR-B (O1))10
- Special Emphasis Panel (ZHL1 CSR-B (O3))6
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2022 | Basic and Translational Studies in Redox Regulation of Cardiovascular Physiology and Disease1R35HL161177-01 | Straub, Adam Carl | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $940,725 | Study section ZHL1 |
| FY2022 | Genomic and Functional Studies of Dysplasia-Associated Arterial Diseases1R35HL161016-01 | Ganesh, Santhi K | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $921,131 | Study section ZHL1 |
| FY2022 | Mechanisms of Alveolar Homeostasis, Injury, Regeneration, and Fibrosis1R35HL160770-01 | Zemans, Rachel Lynne | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $911,296 | Study section ZHL1 |
| FY2022 | Precision nanomedicine targeting novel endothelial mechano-sensing mechanisms1R35HL161244-01 | Fang, Yun | UNIVERSITY OF CHICAGO, IL | First-year cost $805,229 | Study section ZHL1 |
| FY2022 | Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure1R35HL161185-01 | Lavine, Kory J. | WASHINGTON UNIVERSITY, MO | First-year cost $787,500 | Study section ZHL1 |
| FY2021 | Altering Cardiac Cell Fate for Heart Repair1R35HL155656-01 | Qian, Li | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $928,062 | Study section ZHL1 |
| FY2021 | Impact of Infection and Inflammation on Primitive Hematopoiesis1R35HL155672-01 | King, Katherine Yudeh | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $861,734 | Study section ZHL1 |
| FY2021 | Cardiorenal Genomics for Risk Prediction in African Descent Populations1R35HL155466-01 | Irvin, Marguerite R | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | First-year cost $859,443 | Study section ZHL1 |
| FY2021 | Managing Cardiac Toxicities of Cancer Therapy1R35HL155651-01 | Salloum, Fadi N | VIRGINIA COMMONWEALTH UNIVERSITY, VA | First-year cost $776,250 | Study section ZHL1 |
| FY2021 | Harnessing Glycoproteomics and Glycomics to Understand Cardiac Biology and Disease1R35HL155460-01 | Gundry, Rebekah L. | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | First-year cost $765,000 | Study section ZHL1 |
| FY2020 | Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure1R35HL150807-01 | Das, Saumya | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $960,670 | Study section ZHL1 |
| FY2020 | Investigating the heterogeneity and coordination of hematopoietic stem cells1R35HL150826-01 | Lu, Rong | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | First-year cost $950,481 | Study section ZHL1 |
| FY2020 | Genetic and therapeutic studies of hemostatic and thrombotic disorders using zebrafish1R35HL150784-01 | Shavit, Jordan A | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $780,000 | Study section ZHL1 |
| FY2020 | Cellular and molecular programming of lung resident T cell memory1R35HL150803-01 | Kohlmeier, Jacob E | EMORY UNIVERSITY, GA | First-year cost $775,038 | Study section ZHL1 |
| FY2020 | Interrogating stress-relieving neural circuits to alleviate cardiovascular disease1R35HL150750-01 | Krause, Eric Gerald | UNIVERSITY OF FLORIDA, FL | First-year cost $733,362 | Study section ZHL1 |
| FY2020 | Applying Innovative Lung Mapping Strategies to Understand Alveolar Capillary Barrier Permeability in ARDS1R35HL150783-01 | Bastarache, Julie Anne | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | First-year cost $431,819 | Study section ZHL1 |
| FY2019 | Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia1R35HL144805-01 · under RFA-HL-16-025 | Evans, Scott E. | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | First-year cost $893,554 | Study section ZHL1 |
| FY2019 | Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis1R35HL144475-01 · under RFA-HL-16-025 | Leeper, Nicholas James | STANFORD UNIVERSITY, CA | First-year cost $853,060 | Study section ZHL1 |
| FY2019 | Protease-Mediated Vascular Instability in Development and Disease1R35HL144605-01 · under RFA-HL-16-025 | Griffin, Courtney T | OKLAHOMA MEDICAL RESEARCH FOUNDATION, OK | First-year cost $844,478 | Study section ZHL1 |
| FY2019 | Diagnosis, Prevention, And Treatment Of Cardiovascular Diseases With Genome Editing1R35HL145203-01 · under RFA-HL-16-025 | Musunuru, Kiran | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $808,333 | Study section ZHL1 |
| FY2019 | Targeted Molecular Probes for Atherosclerosis Imaging and Therapy1R35HL145212-01 · under RFA-HL-16-025 | Liu, Yongjian | WASHINGTON UNIVERSITY, MO | First-year cost $742,659 | Study section ZHL1 |
| FY2019 | Mechanisms of Platelet Activity in Vascular Disease1R35HL144993-01 · under RFA-HL-16-025 | Berger, Jeffrey S | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | First-year cost $597,921 | Study section ZHL1 |
| FY2019 | Engineering biophysical microtechnologies for hematologic applications in health and disease1R35HL145000-01 · under RFA-HL-16-025 | Lam, Wilbur A | EMORY UNIVERSITY, GA | First-year cost $401,322 | Study section ZHL1 |
| FY2018 | Precision Medicine in the Acute Respiratory Distress Syndrome1R35HL140026-01 · under RFA-HL-16-025 | Calfee, Carolyn | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $986,596 | Study section ZHL1 |
| FY2018 | Systematic Investigation of Protein Ubiquitination in ARDS1R35HL139860-01 · under RFA-HL-16-025 | Chen, Beibei | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $858,906 | Study section ZHL1 |
| FY2018 | Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation1R35HL139926-01 · under RFA-HL-16-025 | Chauhan, Anil Kumar | UNIVERSITY OF IOWA, IA | First-year cost $758,840 | Study section ZHL1 |
| FY2018 | Lung Macrophage Programming in Acute Lung Injury1R35HL140039-01 · under RFA-HL-16-025 | Janssen, William | NATIONAL JEWISH HEALTH, CO | First-year cost $553,487 | Study section ZHL1 |
| FY2017 | Translational Program in CFTR-Related Airway Diseases1R35HL135816-01 · under RFA-HL-16-025 | Rowe, Steven Mark | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | First-year cost $930,091 | Study section ZHL1 |
| FY2017 | Using Genetics to Inform Mechanism of Cardiovascular Disease1R35HL135824-01 · under RFA-HL-16-025 | Willer, Cristen J | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $902,064 | Study section ZHL1 |
| FY2017 | Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis1R35HL135820-01 · under RFA-HL-16-025 | Fernandez Hernando, Carlos | YALE UNIVERSITY, CT | First-year cost $850,059 | Study section ZHL1 |
| FY2017 | Decoding innate immune signaling in normal and myelodysplastic hematopoiesis1R35HL135787-01 · under RFA-HL-16-025 | Starczynowski, Daniel | CINCINNATI CHILDRENS HOSP MED CTR, OH | First-year cost $788,750 | Study section ZHL1 |
| FY2017 | Mechanobiology of Cardiopulmonary Fibrosis1R35HL135790-01 · under RFA-HL-16-025 | Merryman, William D | VANDERBILT UNIVERSITY, TN | First-year cost $764,131 | Study section ZHL1 |
| FY2017 | Program on cellular metabolism and lung fibrosis1R35HL135830-01 · under RFA-HL-16-025 | Liu, Gang | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | First-year cost $742,500 | Study section ZHL1 |
| FY2017 | Cardiovascular Development and Regeneration in Zebrafish1R35HL135831-01 · under RFA-HL-16-025 | Burns, Caroline E | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $427,500 | Study section ZHL1 |
| FY2017 | Renal ion channels in the control of blood pressure1R35HL135749-01 · under RFA-HL-16-025 | Staruschenko, Alexander | MEDICAL COLLEGE OF WISCONSIN, WI | First-year cost $385,000 | Study section ZHL1 |
Newest fiscal year first, then first-year cost.
Patents from its funded projects
6 patents name 3 of the 35 funded projects. The newest 5, by patent number.
- US 12,758,564 (opens the patent at USPTO, a PDF, in a new tab)METHODS AND MATERIALS FOR INHIBITING CB1 ACTIVITYGranted October 13, 2026 to UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATIONR35HL139860 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA
- US 12,606,528 (opens the patent at USPTO, a PDF, in a new tab)METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITYGranted April 21, 2026 to UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATIONR35HL139860 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA
- US 12,428,378 (opens the patent at USPTO, a PDF, in a new tab)METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED AMPK PROTEINGranted September 30, 2025 to University of Pittsburgh—Of the Commonwealth System of Higher EducationR35HL139860 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA
- US 12,337,005 (opens the patent at USPTO, a PDF, in a new tab)METHODS OF TREATING THROMBOSISGranted June 24, 2025 to University of Iowa Research FoundationR35HL139926 · UNIVERSITY OF IOWA, IA
- US 12,286,442 (opens the patent at USPTO, a PDF, in a new tab)METHODS AND MATERIALS FOR INCREASING TRANSCRIPTION FACTOR EB POLYPEPTIDE LEVELSGranted April 29, 2025 to University of Pittsburgh—Of the Commonwealth System of Higher EducationR35HL139860 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.